Stephan Schindler
Chairman at EVOLVA HOLDING SA
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Thomas Meier | M | 56 |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The private company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow.
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | 31 years |
Anne-Kathrin Stoller | M | 50 |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | 18 years |
Günther Loidl | M | 54 |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | 24 years |
Philipp Frech | M | 45 | 2 years | |
Boris Corpataux | M | - | 5 years | |
Alain Schaffter | M | 47 | 3 years | |
Kuno Sommer | M | 68 |
Bachem Americas, Inc.
Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA. | 12 years |
Doris Rudischhauser | F | 57 | - | |
Beat In-Albon | M | 72 | 4 years | |
Nicole Grogg Hötzer | F | 51 | 13 years | |
Fabienne Gschwind | F | 51 | 3 years | |
Manuela Schneider-Höfferer | M | - | 4 years | |
Christoph Schuhr | M | - | 7 years | |
Andreas Pfluger | M | 64 | 2 years | |
Gerhard Lobmaier | M | 55 | 3 years | |
Astrid Schäfer | M | 51 | 6 years | |
Helma Wennemers | M | 55 | 10 years | |
Roland Schürmann | M | 60 | 4 years | |
Julie Marley | M | 58 |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The private company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | - |
Andreas Weigelt | M | 43 | 2 years | |
Peter Zwick | M | 74 |
University Children's Hospital Basel
University Children's Hospital Basel Hospital/Nursing ManagementHealth Services University Children's Hospital Basel provides a large-scale biomedical database and research resource called UK Biobank. The private company is based in Basel, Switzerland. The database contains in-depth genetic and health information from half a million UK participants, which is regularly augmented with additional data. Approved researchers and scientists can access the database to undertake vital research into the most common and life-threatening diseases. UK Biobank has enabled several scientific discoveries that improve human health. | - |
Christoph Breucker | M | 66 | 3 years | |
Christian Wichert | M | 50 | 2 years | |
Steffen Lang | M | 57 | 4 years | |
Chris McGee | M | - | 13 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Thomas Früh | M | 67 | 9 years | |
Lester Mills | M | 66 | 3 years | |
Daniel Erne | M | 72 | 11 years | |
Scott Fabro | M | 60 | 3 years | |
Oliver Walker | M | 55 | 6 years | |
Gerard J. Hoetmer | M | 67 | 4 years | |
Gottlieb Knoch | M | 82 | 9 years | |
Francesco Mennuti | M | 43 | 2 years | |
André Pennartz | M | 50 | 1 years | |
Johann Gottfried Hengartner | M | 80 | 11 years | |
Rolf Nyfeler | M | 74 | - | |
Michael Hüsler | M | 52 | 4 years | |
Richard Ridinger | M | 66 | 2 years | |
José de Chastonay | M | 70 | - | |
Thomas Videbaek | M | 63 | 8 years | |
Jürgen Brokatzky-Geiger | M | 72 | 12 years | |
Carsten Däweritz | M | 51 | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
Switzerland | 41 | 97.62% |
United Kingdom | 2 | 4.76% |
United States | 1 | 2.38% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephan Schindler
- Personal Network